Quick search:
Content Search
Result Content Research
Result Content Research
1 Promising Treatment for Cutaneous T-cell Lymphoma Enters Clinical Trials
2 HyBryte(TM): Addressing an Unmet Need for Rare Lymphoma
3 Cutaneous T-cell lymphoma overall survival associated with TCR clonality, flow cytometry
4 Offering New Hope for a Rare Form of non-Hodgkin's Lymphoma: A Discussion with Dr. Ellen Kim on HyBryte(TM) from Soligenix
5 Shining a Light on a New Hope for a Rare Form of Non-Hodgkins Lymphoma: Conversation with Dr. Ellen Kim on HyBryte™ from Soligenix
6 Federal judge sanctions lawyers who challenged 2020 election results, calls claims 'fantastical' | TheHill
7 A decade on from initial approval, Istodax PTCL indication withdrawn
8 Regular Blood Monitoring and a Tailored Treatment Approach in Mycosis Fungoides and Sézary Syndrome
9 Hendrix College Regional Director of Admission Named to Colleges That Change Lives Board of Directors
10 BMS withdraws Istodax as a treatment for peripheral T-cell lymphoma
11 Ledaga recommended by NICE for rare type of lymphoma
12 Texas Election Reforms Don't Go Far Enough to Protect Against Fraud
13 Bill would prohibit Zuckerbucks in elections – Empower Wisconsin
14 Global Cutaneous T-Cell Lymphoma (CTCL) Clinical Landscape
15 Sponsored by Kyowa Kirin: Understanding the Ins and Outs of CTCL
16 BMS Pulls Istodax in Lymphoma After Trial Failure
17 Proven Clinical Efficacy of Photopheresis for a Range of Medical Conditions spells Growth in Photopheresis Products Market, TMR
18 Study: SGX301 Demonstrates Efficacy for Treatment of Cutaneous T-cell Lymphoma
19 Congress could invest in elections in Dem reconciliation bill
20 LUDWIG, LEE: Left-wing groups flooded Georgia with 'dark money' and mail-in ballots in 2020
21 Potential new drug target to treat cutaneous T cell lymphoma: Drug that blocks methylation restores SATB1 expression and may be effective against disease
22 Zuckerbucks Are Tampering With Your Kids' Education On Top Of Elections
23 Soligenix Receives Pediatric Investigational Plan Waiver for HyBryte™ in CTCL from the European Medicines Agency
24 Soligenix Inc. (NASDAQ: SNGX) Offers Updates in HyBryte and CiVaX Vaccine Development
25 Kyowa Kirin: New Data Analysis Shows Link between Blood Involvement and Response to Treatment in Cutaneous T-cell Lymphoma (CTCL) Patients
26 Science News Releases
27 Mogamulizumab Significantly Boosts Outcomes in CTCL With Blood Involvement
28 Phase 3 Trial of BNZ-1 To Be Initiated for Treatment of Relapsed/Refractory CTCL
29 Federal Lawsuit Filed Over Zuckerberg Grants for Texas Elections
30 Kyowa Kirin Presents New Data on Response to Treatment in Cutaneous T-cell Lymphoma (CTCL) Patients Who Have Blood Involvement
32 SGX301 Demonstrates Positive Benefits for Cutaneous T-Cell Lymphoma
33 Eisai launches Remitoro for PTCL and CTCL in Japan
34 Above the Surface: A Discussion About Cutaneous T-Cell Lymphoma
35 Global Cutaneous T-cell Lymphoma Market Report 2020: Insights, Epidemiology and Forecast, 2017-2030
36 The Scottish Medicines Consortium (SMC) Accepts Kyowa Kirin's POTELIGEO® (mogamulizumab) for the Treatment of Those Living With Certain Ultra-rare Blood Cancers
37 Going Postal: How the Left Will Use Vote by Mail to Federalize Elections
38 Analysis: How Zuckerberg paid millions for progressives to work with 2020 voting officials nationwide
39 First of its kind in Wisconsin | Racine now has its mobile election vehicle, thanks to CTCL grant
40 What the Center for Technology and Civic Life is
41 Antibiotics and Imiquimod for Cutaneous T‐Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure
42 Lawmaker continues to press Missoula County election allegations
43 Kyowa Kirin welcomes the decision that NICE will revisit their appraisal of the innovative systemic treatment, POTELIGEO® (mogamulizumab), for adults living with two forms of ultra-rare non-Hodgkin lymphoma
44 CTCL's “Zuck Bucks” Invade Michigan and Wisconsin
45 Data Set for CTCL Grants to Texas Counties
46 The Zuckerberg Heist will happen again | News, Sports, Jobs
47 ASH 2020: Multi-cytokine Inhibitor Shows Positive Results in Refractory Cutaneous T-Cell Lymphoma
48 Facebook CEO Mark Zuckerberg's charity spent nearly $8 million funding Michigan's elections
49 Trump backers give $5.6M for Senate audit – Arizona Capitol Times
50 Data Set for CTCL Grants to Pennsylvania Counties—UPDATED
51 Folliculotropic Mycosis Fungoides Treatment Market Detailed Analysis with Accurate Forecast by 2030
52 Further lawsuits come from Trump team, watchdog groups
53 Federal Laws Shield Individual Donors To GOP Election Audit
54 Election Irregularities Involving CTCL: Scott Walter Testifies Before Arizona House Committee
55 Mark Zuckerberg, Priscilla Chan donate $100 million more to U.S. election infrastructure
56 Kyowa Kirin North America Announces Recipients of Patient Education Grants to Address Disparities for African-American Patients with Cutaneous T-Cell Lymphomas (CTCL)
57 Amistad Project: Time To Fully Unmask Mark Zuckerberg's $350 Million Funnelled For Election Administration And The Motivation Behind It
58 Soligenix Anticipated to Achieve Multiple Milestones in 2021
59 Photodynamic Therapy SGX301 Continues to Impress in Phase 3 CTCL Trial Update
60 $9.6 Million Zuckerberg Grant, Unvetted Vendors, and Blocked Poll Watchers Add to Harris County Election Controversy
61 Mixed Messages: Mark Zuckerberg and Priscilla Chan's Problematic Democracy Gift — Inside Philanthropy
62 Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma
63 Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma
64 Amistad Project: Federal Lawsuits Filed To Challenge Use Of Zuckerberg Millions, Claims Funds Used To Influence Election Outcome In Battleground States
65 Why Conservatives' Attempts to Prevent $300 Million in Election Grants From Reaching States Will Fail –
66 How Mark Zuckerberg Meddled in Virginia's 2020 Election—UPDATED
67 Broad Efficacy and Improved Safety Profile of HyBryte™ Presented at Society for Investigative Dermatology Virtual Meeting
68 BioInvent has enrolled first patient in a Phase I/IIa trial of the first-in-class anti-TNFR2 antibody BI-1808 for the treatment of patients with solid tumors and CTCL
69 Facebook targeted Texas’ largest counties to primarily influence Democratic turnout in election, report alleges
70 Georgia Election Officials, a Billionaire, and the “Nonpartisan” Center for Tech & Civic Life
71 Cutaneous T-Cell Lymphoma Symptoms and Treatment
72 Trump supporters have sunk nearly $6M into Arizona audit
73 Go toward the light: Soligenix CTCL therapy no FLASH in the pan
74 New Lacutamab Data from TELLOMAK Trial to be Showcased in
75 Emails Show Likely Illegality In The Way Milwaukee Ran The Presidential Election
76 Novel Photodynamic Therapy Active in CTCL
77 How Mark Zuckerberg Almost Handed Texas To The Democrats
78 Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTC | CMAR
79 Antibiotics thwart disease activity in advanced cutaneous T-cell lymphoma
80 Lawsuit Exposes Arabella Advisors and Zuckerberg Meddling in Louisiana's Elections
81 Former Kansas AG says Zuckerberg funded a shadow campaign against Trump
82 Legislature passes second attempt to prohibit election donations
83 New Data from MAVORIC Trial Sheds Light on Key Characteristics of Long-term POTELIGEO® (mogamulizumab-kpkc) Responders with Specific Subtypes of Cutaneous T-cell Lymphoma
84 What are Indolent Lymphomas and How Are They Treated? | Dana-Farber
85 Elorac Biotherapeutics Announces Amendment to Naloxone Lotion Phase III Study For Increased Access to Patients
86 The New New Organizing Institute
87 Volcani Center Announces Significant Breakthroughs in CTCL Skin Cancer Cannabis Treatment Development in Cooperation With MedC Biopharma Corporation of Canada
88 The Cybersecurity 202: Courts rule election money from Facebook founder will stay despite conservative attempts to reverse it
89 Should a billionaire run Arizona's elections? – Arizona Capitol Times
90 BRIEF—Eisai gets approval for Remitoro in Japan
91 Complaint Challenges Use Of Zuckerberg's $250 Mil By Cities To Impact Election Outcome
92 Another lawsuit filed in Michigan | News, Sports, Jobs
93 Group sues to stop 5 large cities from using grants to aid election, calls it bribery
94 Mark Zuckerberg’s election donation leaves election officials scrambling
95 FDA Approves New Drug for Cutaneous T-Cell Lymphomas
96 Dallas County Elections Department Receives Over $15 Million Grant Center for Tech and Civic Life
97 Malkin: The Zuckerberg heist
98 'Not Plan A': Charities are stepping up to pay for elections
99 Zuckerberg’s $45M for Georgia elections boosted Dem turnout, watchdog report says
100 CTCL Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight